François Bachand

Tetreault-Laflamme A, Crook J, Hamm J, Pickles T, Keyes M, McKenzie M, Pai H, Bachand F, Morris J

Long-Term Prostate Specific Antigen Stability and Predictive Factors of Failure after Permanent Seed Prostate Brachytherapy

J Urol, 199 (1), 2018.

Résumé | Liens:

Korzeniowski MA, Crook JM, Bowes D, Gaztañaga M, Ots A, Jazwal J, Rose J, Tétreault-Laflamme A, Pilote L, Halperin R, Kim D, Petrik D, Araujo C, Bachand F

A Phase II trial of 8 weeks of degarelix for prostate volume reduction: Efficacy and hormonal recovery

Brachytherapy, 17 (3), 2018.

Résumé | Liens:

Parimi S, Tsang E, Alexander A, Mckenzie M, Bachand F, Sunderland K, Chi KN, Aparicio M, Worsley D, Tyldesley S

A population-based study of the use of radium 223 in metastatic castration-resistant prostate cancer: Factors associated with treatment completion

Can Urol Assoc J, 11 (10), 2017.

Résumé | Liens:

Kirchheiner K, Pötter R, Tanderup K, Lindegaard JC, Haie-Meder C, Petrič P, Mahantshetty U, Jürgenliemk-Schulz IM, Rai B, Cooper R, Dörr W, Nout RA,

Health-Related Quality of Life in Locally Advanced Cervical Cancer Patients After Definitive Chemoradiation Therapy Including Image Guided Adaptive Brachytherapy: An Analysis From the EMBRACE Study

Int J Radiat Oncol Biol Phys, 94 (5), 2016.

Résumé | Liens:

Hilts M, Halperin H, Morton D, Batchelar D, Bachand F, Chowdhury R, Crook J

Skin dose in breast brachytherapy: Defining a robust metric

Brachytherapy, 14 (6), 2015.

Résumé | Liens:

Keyes M, Pickles T, Crook J, McKenzie M, Cheung A, Spadinger I, LaPointe V, Bachand WF, Morris J

Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy

Brachytherapy, 14 (3), 2015.

Résumé | Liens:

Tetreault-Laflamme A, Bachand F

Grade 3 Radiation Recall Sigmoiditis after Treatment for Locally Advanced Cervical Cancer: A Case Report

Cureus, 7 (10), 2015.

Résumé | Liens:

Crook J, Ots A, Gaztañaga M, Schmid M, Araujo C, Hilts M, Batchelar D, Parker B, Bachand F, Milette MP

Ultrasound-planned high-dose-rate prostate brachytherapy: dose painting to the dominant intraprostatic lesion

Brachytherapy, 13 (5), 2014.

Résumé | Liens:

Batchelar D, Gaztañaga M, Schmid M, Araujo C, Bachand F, Crook J

Validation study of ultrasound-based high-dose-rate prostate brachytherapy planning compared with CT-based planning

Brachytherapy, 13 (1), 2014.

Résumé | Liens:

Bachand F, Martin AG, Beaulieu L, Harel F, Vigneault E

An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome

Int J Radiat Oncol Biol Phys, 73 (3), 2009.

Résumé | Liens: